Loading clinical trials...

Avatrombopag Combined With IST as First-line Treatment for SAA | Clinical Trials | Clareo Health

UNKNOWNPhase 2NCT05720234

Avatrombopag Combined With IST as First-line Treatment for SAA

This single-center study aims to evaluate the early efficacy and safety of avatrombopag combined with immunosuppressive therapy (IST) in the first-line treatment of severe aplastic anemia (SAA).

Lead sponsor: Institute of Hematology & Blood Diseases Hospital, China•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Xin Zhao, M.D

CONTACT

8613702041366 zhaoxin@ihcams.ac.cn

Related studies

RECRUITINGPhase 2

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

NCT03520647 · Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), and more

RECRUITING

Natural History of Acquired and Inherited Bone Marrow Failure Syndromes

NCT05012111 · Severe Aplastic Anemia, Telomere Biology Disorders, and more

RECRUITINGPhase 2

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

NCT04304820 · Severe Aplastic Anemia

RECRUITINGPhase 2

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

NCT03579875 · Fanconi Anemia, Severe Aplastic Anemia, and more

RECRUITINGPhase 2

Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

NCT02828592 · Severe Aplastic Anemia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 9, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment53

Start dateNov 2022

Last updatedFeb 9, 2023

Condition

Severe Aplastic Anemia

Locations shown

Institute of Hematology & Blood Diseases Hospital

Tianjin, Tianjin Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 9, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Avatrombopag Combined With IST as First-line Treatment for SAA

What this study is about

Save this trial guide to your notes

Contacts

Sponsors

Related studies

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Natural History of Acquired and Inherited Bone Marrow Failure Syndromes

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

Trial snapshot

Condition

Locations shown

For caregivers